Composition:

Bisocard 5 mg film-coated tablet

Therapeutic Indications:

Treatment of hypertension.

Treatment of stable chronic angina.

reatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE

inhibitors, and diuretics, and optionally cardiac glycosides.

Approved by Egyptian Drug Authority: HF0294OA4548/102025 . Invalidation date: 20/10/2026

Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at www.edaegypt.gov.eg”